TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
Petrova, Penka S, Viller, Natasja Nielsen, Wong, Mark, Pang, Xinli, Lin, Gloria H Y, Dodge, Karen, Chai, Vien, Chen, Hui, Lee, Vivian, House, Violetta, Vigo, Noel T, Jin, Debbie, Mutukura, Tapfuma, Charbonneau, Marilyse, Truong, Tran, Viau, Stephane, Johnson, Lisa D, Linderoth, Emma, Sievers, Eric L, Maleki Vareki, Saman, Figueredo, Rene, Pampillo, Macarena, Koropatnick, James, Trudel, Suzanne, Mbong, Nathan, Jin, Liqing, Wang, Jean C Y, Uger, Robert A
Published in Clinical cancer research (15.02.2017)
Published in Clinical cancer research (15.02.2017)
Get full text
Journal Article
Blockade Of CD47 Using SIRPαFc: Role Of The Fc Region In Anti-Leukemic Activity and Tolerability
Uger, Robert A., Pang, Xinli, Wong, Mark, House, Violetta, Dodge, Karen, Viau, Stephane, Vigo, Noel T., Tam, Debbie, Truong, Tran, Jin, Liqing, Malko, Andrei V., Ho, Jenny, Prasolava, Tatiana K., Danska, Jayne S., Wang, Jean C.Y., Petrova, Penka S.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article